Latest Breaking News On - Fennec pharmaceuticals inc - Page 5 : comparemela.com
Fennec Pharmaceuticals Inc (NASDAQ:FENC), a biopharmaceutical company focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients, has reported a significant insider sell transaction.
Fennec-pharmaceuticals-incPharmaceuticalsRosty-raykov